Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 700 of 2228 entries
View as:

Actual Use Study of Tamsulosin in Men

Phase: N/A Priority: Normal
NCT ID: NCT02573311 Org: User:
Start: 09/23/15 End: 08/01/16 Due: 08/01/17

A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01903356 Org: User:
Start: 07/11/13 End: 06/10/17 Due: 06/10/18

A Study to Test How BI 1015550 is Taken up in the Blood of People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT05661344 Org: User:
Start: 02/07/23 End: 09/13/23 Due: 09/13/24

Digital Auscultation Test - IPF Data Collection

Phase: N/A Priority: Normal
NCT ID: NCT03503188 Org: User:
Start: 03/28/18 End: 01/03/19 Due: 01/03/20

BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit

Phase: N/A Priority: Normal
NCT ID: NCT02211872 Org: User:
Start: 08/31/04 End: - Due: -

Bioequivalence of Telmisartan Film-coated Tablet Compared With the Conventional Telmisartan Tablet Following Oral Administration in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02263989 Org: User:
Start: 01/31/07 End: - Due: -

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259959 Org: User:
Start: 04/30/07 End: - Due: -

The Effect of Sifrol® on Tremor and Depression in Patients With Idiopathic Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231294 Org: User:
Start: 07/31/00 End: - Due: -

Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02702011 Org: User:
Start: 03/20/16 End: 10/03/16 Due: 10/03/17

EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)

Phase: N/A Priority: Normal
NCT ID: NCT03057951 Org: User:
Start: 03/02/17 End: 04/26/21 Due: 04/26/22

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT02236741 Org: User:
Start: 11/30/09 End: - Due: -

Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02209649 Org: User:
Start: 10/31/99 End: - Due: -

The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183623 Org: User:
Start: 09/30/05 End: - Due: -

Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194309 Org: User:
Start: 09/30/06 End: - Due: -

6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab

Phase: N/A Priority: Normal
NCT ID: NCT00826267 Org: User:
Start: 01/31/09 End: - Due: -

Efficacy, Tolerability and Safety of ALNA® in Patients With Benign Prostatic Syndrome (BPS)

Phase: N/A Priority: Normal
NCT ID: NCT02244333 Org: User:
Start: 02/29/04 End: - Due: -

INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT00153088 Org: User:
Start: 01/31/03 End: 11/30/05 Due: 11/30/06

Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02238106 Org: User:
Start: 09/30/05 End: - Due: -

Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset

Phase: N/A Priority: Normal
NCT ID: NCT02930837 Org: User:
Start: 11/15/16 End: 12/11/17 Due: 12/11/18

A Study to Test How BI 1291583 is Taken up in the Blood of People With and Without Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT07023354 Org: User:
Start: 06/25/25 End: 03/20/26 Due: 03/20/27

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01896297 Org: User:
Start: 07/31/13 End: 10/31/15 Due: 10/31/16

Postmarketing Surveillance Study to Assess Handling and Patient Satisfaction on Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02231320 Org: User:
Start: 12/31/05 End: - Due: -

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT05321069 Org: User:
Start: 10/06/22 End: 12/17/24 Due: 12/17/25

Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)

Phase: N/A Priority: Normal
NCT ID: NCT00034853 Org: User:
Start: 12/31/00 End: - Due: -

Efficacy and Safety of Linagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00954447 Org: User:
Start: 08/31/09 End: - Due: -